360O_PR Efficacy and safety of nivolumab for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Asia: CheckMate 141 subgroup analysis
Titel:
360O_PR Efficacy and safety of nivolumab for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in Asia: CheckMate 141 subgroup analysis
Auteur:
Hasegawa, Y. Kiyota, N. Takahashi, S. Yokota, T. Yen, C.-J. Iwae, S. Shimizu, Y. Hong, R.-L. Goto, M. Namba, Y. Ferris, R.L. Monga, M. Lynch, M. Hagihara, S. Tahara, M.